H.C. Wainwright maintains $5 target on Oncolytics Biotech stock
H.C. Wainwright reaffirmed a Buy rating on Oncolytics Biotech (NASDAQ:ONCY) shares with a steady price target of $5.00. The stock, currently trading at $0.73 and near its 52-week low, shows potential ...
Replimune: A Misunderstood Contender In Oncolytics
Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...
Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
Zacks.com on MSN8d
Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock?
Oncolytics Biotech Inc. (ONCY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
Yahoo Finance6d
Oncolytics Biotech And 2 Other Promising Penny Stocks On The TSX
Overview: Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing pharmaceutical products for cancer treatment, with a market cap of CA$80.93 ...
Morningstar23d
Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium
SAN DIEGO and CALGARY, AB, Jan. 22, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology ...
KTLA1mon
Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
SAN DIEGO and CALGARY, AB, Jan. 15, 2025 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology ...
Seeking Alpha28d
ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc. (ONCY) stock price is 0.79 and Oncolytics Biotech Inc. (ONCY) 10-day simple moving average is 0.88. Oncolytics Biotech Inc. (ONCY) stock price is 0.79 and Oncolytics ...
Morningstar6d
Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence
SAN DIEGO and CALGARY, AB, Feb. 7, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology ...